Adverse event profile of lorazepam: a real-world pharmacovigilance study using the FDA adverse event reporting system database

• Հիմնական հեղինակներ: Zhengkang Su (Հեղինակ), Zhengwei Huang (Հեղինակ), Xiaoyu Chen (Հեղինակ), Xi Li (Հեղինակ)
• Ձևաչափ: Գիրք
• Հրապարակվել է: Frontiers Media S.A., 2024-11-01T00:00:00Z.
• Խորագրեր: article
• Առցանց հասանելիություն: Connect to this object online.

IntroductionAnxiety diagnoses have surged recently during and after the COVID-19 pandemic. Lorazepam is widely recognized for its efficacy in treatment of anxiety, as well as insomnia, etc. However, the long-term safety profile of lorazepam in extensive patient populations has not been thoroughly es...